Renovis Pursuing REN-1654 In Sciatica Despite PHN Trial Data March 9, 2005 By Jennifer Boggs No Comments
Allos Secures $50M Investment For Efaproxyn Phase III Program March 4, 2005 By Jennifer Boggs No Comments
Allos Secures $50M Investment For Efaproxyn Phase III Program March 4, 2005 By Jennifer Boggs No Comments
Osel Gains Lead Bacteria-Based Product Through Licensing Deal March 3, 2005 By Jennifer Boggs No Comments
Osel Gains Lead Bacteria-Based Product Through Licensing Deal March 3, 2005 By Jennifer Boggs No Comments
Discovery Acquires Biofrontera, Expects To Lose Money In 2005 March 2, 2005 By Jennifer Boggs No Comments